• SPX
  • $5,544.59
  • -0.78 %
  • -$43.68
  • DJI
  • $40,665.02
  • -1.29 %
  • -$533.08
  • N225
  • $39,952.62
  • -0.43 %
  • -$173.73
  • FTSE
  • $8,204.89
  • 0.21 %
  • $17.43
  • IXIC
  • $17,871.22
  • -0.7 %
  • -$125.70

XOMA Corporation (XOMA) Stock Price, News & Analysis

Currency in USD Disclaimer

$27.48

-$1.25

(-4.36%)

Day's range
$27
$28.99
52 wk range
$13.48
$29
50-day range
$21.27
$29
  • Country: US
  • ISIN: US98419J2069
XOMA Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -6.05
  • Piotroski Score 4.00
  • Grade Buy
  • Symbol (XOMA)
  • Company XOMA Corporation
  • Price $27.48
  • Changes Percentage (-4.36%)
  • Change -$1.25
  • Day Low $27.00
  • Day High $28.99
  • Year High $29.00

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners. It has a portfolio with approximately 70 assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.

  • Last Earnings N/A
  • Ex-Dividend for 5/16 Dividend 04/02/2024
  • Dividend Payable N/A
  • Today N/A
  • Next Earnings (Estimated) 08/06/2024
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Buy
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$3.92
  • Trailing P/E Ratio -6.14
  • Forward P/E Ratio -6.14
  • P/E Growth -6.14
  • Net Income $-40,831,000

Income Statement

Quarterly

Annual

Latest news of XOMA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Log In


or

Continue with Google Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to StockNews!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.